top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Anticancer Inhibitors
Anticancer Inhibitors
Autore Fantacuzzi Marialuigia
Pubbl/distr/stampa Basel, : MDPI Books, 2022
Descrizione fisica 1 electronic resource (216 p.)
Soggetto topico Research & information: general
Chemistry
Soggetto non controllato breast cancer
tamoxifen
LY294002
synergism
apoptosis
cell cycle
tea (Camellia sinensis) flowers
BTFS
A2780/CP70 ovarian cancer cells
S phase cell cycle arrest
nicotinamide phosphoribosyltransferase
NAD+ biosynthesis
inhibitor
azacyclohexane
anticancer drug
drug design
enthalpy effect
NSCLC
Cathepsin K
cell proliferation
cell migration
cell invasion
mTOR
isatin-hydrazones
cytotoxicity
CDK2 inhibitor
ATP competitive inhibitor
ADME analysis
receptor tyrosine kinases
protein-protein interactions
protein engineering
directed evolution
angiogenesis
binding affinity
agonistic activity
saponins
phytochemicals
tea (Camellia sinensis) flower
ovarian cancer
autophagy
ZMYND8
tumorigenesis
epigenetic regulation
pro-oncogenic effects
tumor suppression
tacrine-coumarin derivatives
DNA
topoisomerases I, II
lung carcinoma cells
A549
chemotherapy
prodrug
drug targeting
overexpressed enzymes
ADC
ADEPT
GDEPT
LEAPT
PROTAC
cyclin-dependent kinase
cancer
resistance
small molecule inhibitors
PROTACs
statins
pancreatic cancer
DNA microarray
pitavastatin
cerivastatin
simvastatin
fluvastatin
atorvastatin
pravastatin
HMG-CoA reductase inhibitors
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910595069203321
Fantacuzzi Marialuigia  
Basel, : MDPI Books, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Monoclonal Antibodies and Their Functional Fragments in Research, Diagnosis and Therapy
Monoclonal Antibodies and Their Functional Fragments in Research, Diagnosis and Therapy
Autore Ruvo Menotti
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (278 p.)
Soggetto topico Technology: general issues
Soggetto non controllato porcine deltacoronavirus
nucleocapsid
monoclonal antibodies
neurodegenerative disorders
affibody molecules
blood–brain barrier
receptor-mediated transcytosis
transferrin receptor
AL amyloidosis
CD38
anti-CD38 MoAb
Daratumumab
Isatuximab
myeloma
BCMA
bispecific T-cell engager
antibody-drug conjugates
chimeric antigen receptor T-cells
belantamab mafodotin
idecabtagene vicleucel
JNJ-68284528
Mabs
Antibody-Drug Conjugate
cancer therapy
drug targeting
payload
cross-linking
antibody fragment
Fab
scFv
E. coli
YKL-40
CHI3L1
monoclonal antibody
phage display
lung metastasis
prostate-specific membrane antigen
in vivo imaging
prostate cancer
glutamate carboxypeptidase II
NAALADase
immunization
antibody
protocol
guinea pig
cDNA
chimeric antigen receptor (CAR T)
universal CAR T
modular CAR T
universal immune receptor
CAR adaptor
adoptive immunotherapy
split CAR
bispecific
polyspecificity
pharmacokinetics
solubility
aggregation
viscosity
developability
stability
affinity
specificity
protein engineering
self-association
non-specific binding
immunogenicity
antibody fragments
single chain
amyloid
oligomer
neurotoxicity
NUsc1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557613003321
Ruvo Menotti  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Nanomaterials for Biomedical and Biotechnological Applications
Nanomaterials for Biomedical and Biotechnological Applications
Autore Ferraro Angelo
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (266 p.)
Soggetto topico Technology: general issues
Biotechnology
Soggetto non controllato neurodegenerative disease
cerium oxide nanoparticles
Parkinson's disease
oxidative stress
physicochemical properties
blood-brain barrier
synthesis methods
magnetic driving
magnetic nanoparticles
actuation system
drug targeting
chitosan
clay
nanocomposite films
papain
covalent immobilization
wine
magnetic gels
drug release
magnetic hyperthermia
magnetic lipogels
supramolecular hydrogels
self-assembly
nanoparticle functionalization
organic and inorganic nanoparticles
ophthalmic applications
clinical trials
orthopedic
nanomedicine
nanomodified surfaces
animal model
immune response
Chlorella vulgaris
microwave-synthesized magnetite particles
response surface methodology
harvesting process optimization
optimization
economic analysis
plant design and process engineering
cubic particles
COVID-19
nanotechnology
vaccines
sanitizers
biosensors
restricted access media
nanofibers
microfibers
on-line extraction
biological samples
column-switching chromatography
theranostic nanomaterials
boron nitride
neutron capture reaction
nuclear medicine
drug delivery
antibiotics
antimicrobial resistance
gold nanoparticles
ciprofloxacin
Enterococcus faecalis
liver and kidney infections
colorectal cancer
biomarkers
cytotoxic medication
genetic pathways
epigenetic changes
prognostic
phytomedicine
rheumatoid arthritis
methotrexate
anti-arthritic activity
nanoemulsion
hemocompatibility
MTT assay
stability studies
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910585937903321
Ferraro Angelo  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui